Inflammation and melanoma metastasis

Pigment Cell and Melanoma Research

Volumn 22, Issue 3, 2009, Pages 257-267

  Melnikova, Vladislava O ^a   Bar Eli, Menashe ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Melanoma; Metastasis; Microenvironment; PAR1; Platelet activating factor; Platelets; Thrombin receptor; Tumor

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; G PROTEIN COUPLED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANGIOGENESIS; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; KERATINOCYTE; MACROPHAGE; MAST CELL; MELANOMA; METASTASIS; MUTATION; NEUTROPHIL; NONHUMAN; REVIEW; STROMA CELL; THROMBOCYTE ACTIVATION; TUMOR CELL;

CHEMOKINES; DISEASE PROGRESSION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKINS; KERATINOCYTES; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLATELET ACTIVATING FACTOR; PLATELET ACTIVATION; RECEPTOR, PAR-1; STROMAL CELLS;

EID: 65549085700     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00570.x     Document Type: Review

References (141)

1. Acosta, J.C. Gil, J. (2009). A role for CXCR2 in senescence, but what about in cancer? Cancer Res. 69, 2167 2170.
2. Acosta, J.C., O'Loghlen, A., Banito, A. et al. (2008). Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006 1018.
3. Atkins, M.B. (2006). Cytokine-based therapy and biochemotherapy for advanced melanoma. Clin. Cancer Res. 12, 2353s 2358s.
4. Axelrad, T.W., Deo, D.D., Ottino, P., Van Kirk, J., Bazan, N.G., Bazan, H.E. Hunt, J.D. (2004). Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J. 18, 568 570.
5. Balentien, E., Mufson, B.E., Shattuck, R.L., Derynck, R. Richmond, A. (1991). Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 6, 1115 1124. (Pubitemid 21924197)
6. Bedikian, A.Y., Johnson, M.M., Warneke, C.L., McIntyre, S., Papadopoulos, N., Hwu, W.J., Kim, K. Hwu, P. (2008). Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. J. Immunotoxicol. 5, 201 207.
7. Bedogni, B., Welford, S.M., Cassarino, D.S., Nickoloff, B.J., Giaccia, A.J. Powell, M.B. (2005). The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 8, 443 454. (Pubitemid 41773448)
8. Bedogni, B., Warneke, J.A., Nickoloff, B.J., Giaccia, A.J. Powell, M.B. (2008). Notch1 is an effector of Akt and hypoxia in melanoma development. J. Clin. Invest. 118, 3660 3670.
9. Benveniste, J., Henson, P.M. Cochrane, C.G. (1972). Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136, 1356 1377.
10. Benveniste, J., Tence, M., Varenne, P., Bidault, J., Boullet, C. Polonsky, J. (1979). Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine. C. R. Acad. Sci., D, Sci. Nat. 289, 1037 1040.
11. Bito, H., Honda, Z., Nakamura, M. Shimizu, T. (1994). Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur. J. Biochem. 221, 211 218. (Pubitemid 24120564)
12. Blank, M.L., Snyder, F., Byers, L.W., Brooks, B. Muirhead, E.E. (1979). Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem. Biophys. Res. Commun. 90, 1194 1200. (Pubitemid 10195924)
13. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S. Kuliopulos, A. (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303 313. (Pubitemid 40222426)
14. Boucharaba, A., Serre, C.M., Gres, S., Saulnier-Blache, J.S., Bordet, J.C., Guglielmi, J., Clezardin, P. Peyruchaud, O. (2004). Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J. Clin. Invest. 114, 1714 1725. (Pubitemid 40385527)
15. de Braud, F., Khayat, D., Kroon, B.B., Valdagni, R., Bruzzi, P. Cascinelli, N. (2003). Malignant melanoma. Crit. Rev. Oncol. Hematol. 47, 35 63. (Pubitemid 36805636)
16. Brizzi, M.F., Battaglia, E., Montrucchio, G., Dentelli, P., Del Sorbo, L., Garbarino, G., Pegoraro, L. Camussi, G. (1999). Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ. Res. 84, 785 796. (Pubitemid 29181485)
17. Bromberg, M.E., Konigsberg, W.H., Madison, J.F., Pawashe, A. Garen, A. (1995). Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. U S A 92, 8205 8209.
18. Bussolati, B., Biancone, L., Cassoni, P., Russo, S., Rola-Pleszczynski, M., Montrucchio, G. Camussi, G. (2000). PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am. J. Pathol. 157, 1713 1725.
19. Bussolino, F., Arese, M., Montrucchio, G. et al. (1995). Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest. 96, 940 952.
20. Byrne, S.N., Knox, M.C. Halliday, G.M. (2008). TGFbeta is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction. Immunol. Cell Biol. 86, 92 97.
21. Camussi, G., Montrucchio, G., Lupia, E., De Martino, A., Perona, L., Arese, M., Vercellone, A., Toniolo, A. Bussolino, F. (1995). Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. Immunol. 154, 6492 6501.
22. Camussi, G., Montrucchio, G., Lupia, E., Soldi, R., Comoglio, P.M. Bussolino, F. (1997). Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J. Immunol. 158, 1302 1309. (Pubitemid 127469955)
23. Chiang, A.C. Massague, J. (2008). Molecular basis of metastasis. N. Engl. J. Med. 359, 2814 2823.
24. Colombo, M.P., Maccalli, C., Mattei, S., Melani, C., Radrizzani, M. Parmiani, G. (1992). Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines. Melanoma Res. 2, 181 189.
25. Countryman, N.B., Pei, Y., Yi, Q., Spandau, D.F. Travers, J.B. (2000). Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. J. Invest. Dermatol. 115, 267 272. (Pubitemid 30637197)
26. Coussens, L.M., Tinkle, C.L., Hanahan, D. Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481 490.
27. Crowson, A.N., Magro, C., Miller, A. Mihm, M.C. Jr. (2007). The molecular basis of melanomagenesis and the metastatic phenotype. Semin. Oncol. 34, 476 490. (Pubitemid 350245678)
28. Cucina, A., Borrelli, V., Di Carlo, A., Pagliei, S., Corvino, V., Santoro-D'Angelo, L., Cavallaro, A. Sterpetti, A.V. (1999). Thrombin induces production of growth factors from aortic smooth muscle cells. J. Surg. Res. 82, 61 66. (Pubitemid 29394154)
29. De Fabo, E.C., Noonan, F.P., Fears, T. Merlino, G. (2004). Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res. 64, 6372 6376. (Pubitemid 39297887)
30. De Palma, M., Venneri, M.A., Galli, R., Sergi Sergi, L., Politi, L.S., Sampaolesi, M. Naldini, L. (2005). Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211 226. (Pubitemid 41317592)
31. Demopoulos, C.A., Pinckard, R.N. Hanahan, D.J. (1979). Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3- phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254, 9355 9358. (Pubitemid 10248704)
32. Denardo, D.G., Johansson, M. Coussens, L.M. (2008). Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev. 27, 11 18.
33. Deo, D.D., Axelrad, T.W., Robert, E.G., Marcheselli, V., Bazan, N.G. Hunt, J.D. (2002). Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J. Biol. Chem. 277, 21237 21245.
34. Deo, D.D., Bazan, N.G. Hunt, J.D. (2004). Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. J. Biol. Chem. 279, 3497 3508. (Pubitemid 38140589)
35. Di Cesare, S., Marshall, J.C., Logan, P., Antecka, E., Faingold, D., Maloney, S.C. Burnier, M.N. Jr. (2007). Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF. J. Carcinog. 6, 2. (Pubitemid 46243447)
36. Duncan, L.M., Richards, L.A. Mihm, M.C. Jr. (1998). Increased mast cell density in invasive melanoma. J. Cutan. Pathol. 25, 11 15. (Pubitemid 28059589)
37. Dy, L.C., Pei, Y. Travers, J.B. (1999). Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. J. Biol. Chem. 274, 26917 26921. (Pubitemid 129520214)
38. Elliott, R.L. Blobe, G.C. (2005). Role of transforming growth factor Beta in human cancer. J. Clin. Oncol. 23, 2078 2093. (Pubitemid 46211385)
39. Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I. Bar-Shavit, R. (1998). Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4, 909 914. (Pubitemid 28364029)
40. Even-Ram, S.C., Maoz, M., Pokroy, E., Reich, R., Katz, B.Z., Gutwein, P., Altevogt, P. Bar-Shavit, R. (2001). Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin. J. Biol. Chem. 276, 10952 10962. (Pubitemid 38089274)
41. Fallani, A., Calorini, L., Mannini, A., Gabellieri, S., Mugnai, G. Ruggieri, S. (2006). Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. Prostaglandins Other Lipid Mediat. 81, 171 177. (Pubitemid 44666500)
42. Fidler, I.J. (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453 458. (Pubitemid 37328849)
43. Fidler, I.J., Kim, S.J. Langley, R.R. (2007). The role of the organ microenvironment in the biology and therapy of cancer metastasis. J. Cell. Biochem. 101, 927 936. (Pubitemid 47040873)
44. Fischer, E.G., Ruf, W. Mueller, B.M. (1995). Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res. 55, 1629 1632.
45. Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J.F., Harrington, K. Sahai, E. (2007). Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 1392 1400. (Pubitemid 350201752)
46. Gasic, G.J., Gasic, T.B. Stewart, C.C. (1968). Antimetastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci. U S A 61, 46 52.
47. Graves, D.T., Barnhill, R., Galanopoulos, T. Antoniades, H.N. (1992). Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 140, 9 14.
48. Haass, N.K. Herlyn, M. (2005). Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J. Investig. Dermatol. Symp. Proc. 10, 153 163.
49. Hansen, K.K., Saifeddine, M. Hollenberg, M.D. (2004). Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells. Immunology 112, 183 190.
50. Haralabopoulos, G.C., Grant, D.S., Kleinman, H.K. Maragoudakis, M.E. (1997). Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am. J. Physiol. 273, C239 C245. (Pubitemid 27343971)
51. Hendrix, M.J., Seftor, E.A., Hess, A.R. Seftor, R.E. (2003). Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3, 411 421. (Pubitemid 37328845)
52. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290 302. (Pubitemid 44015592)
53. Hsu, M.Y., Meier, F. Herlyn, M. (2002). Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70, 522 536. (Pubitemid 36194317)
54. Huang, Y.Q., Li, J.J., Hu, L., Lee, M. Karpatkin, S. (2001). Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb. Haemost. 86, 1094 1098. (Pubitemid 32975838)
55. Im, S.Y., Ko, H.M., Kim, J.W. et al. (1996). Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 56, 2662 2665. (Pubitemid 26170704)
56. Ishii, S., Nagase, T., Tashiro, F., Ikuta, K., Sato, S., Waga, I., Kume, K., Miyazaki, J. Shimizu, T. (1997). Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16, 133 142. (Pubitemid 27032856)
57. Javelaud, D., Alexaki, V.I. Mauviel, A. (2008). Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res. 21, 123 132.
58. Karpatkin, S. Pearlstein, E. (1981). Role of platelets in tumor cell metastases. Ann. Intern. Med. 95, 636 641. (Pubitemid 12231807)
59. Kaushal, V., Kohli, M., Dennis, R.A., Siegel, E.R., Chiles, W.W. Mukunyadzi, P. (2006). Thrombin receptor expression is upregulated in prostate cancer. Prostate 66, 273 282. (Pubitemid 43191227)
60. Kirkwood, J.M., Tarhini, A.A., Panelli, M.C., Moschos, S.J., Zarour, H.M., Butterfield, L.H. Gogas, H.J. (2008). Next generation of immunotherapy for melanoma. J. Clin. Oncol. 26, 3445 3455.
61. Ko, H.M., Kang, J.H., Jung, B., Kim, H.A., Park, S.J., Kim, K.J., Kang, Y.R., Lee, H.K. Im, S.Y. (2007). Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis. Int. J. Cancer 120, 1277 1283. (Pubitemid 46256781)
62. Koga, M., Kai, H., Egami, K. et al. (2008). Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem. Biophys. Res. Commun. 365, 279. (Pubitemid 350137285)
63. Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J. Peeper, D.S. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019 1031.
64. Kusmartsev, S., Nagaraj, S. Gabrilovich, D.I. (2005). Tumor-associated CD8 + T cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175, 4583 4592. (Pubitemid 41361997)
65. Lawson, D.H., Thomas, H.G., Roy, R.G., Gordon, D.S., Chawla, R.K., Nixon, D.W. Richmond, A. (1987). Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells. J. Cell. Biochem. 34, 169 185. (Pubitemid 17089659)
66. Lee, J.T. Herlyn, M. (2007). Microenvironmental influences in melanoma progression. J. Cell. Biochem. 101, 862 872. (Pubitemid 47040868)
67. Li, J.J., Huang, Y.Q., Basch, R. Karpatkin, S. (2001). Thrombin induces the release of angiopoietin-1 from platelets. Thromb. Haemost. 85, 204 206. (Pubitemid 32140561)
68. Li, G., Satyamoorthy, K., Meier, F., Berking, C., Bogenrieder, T. Herlyn, M. (2003). Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 22, 3162 3171. (Pubitemid 36713768)
69. Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K. Flavell, R.A. (2006). Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99 146.
70. Liu, Z.J., Xiao, M., Balint, K., Smalley, K.S., Brafford, P., Qiu, R., Pinnix, C.C., Li, X. Herlyn, M. (2006). Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 66, 4182 4190.
71. Lo, R.S. Witte, O.N. (2008). Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes. Cancer Res. 68, 4248 4257.
72. Lopez-Bergami, P., Huang, C., Goydos, J.S. et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447 460. (Pubitemid 46670078)
73. Maliba, R., Lapointe, S., Neagoe, P.E., Brkovic, A. Sirois, M.G. (2006). Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. Cell. Signal. 18, 1947 1957. (Pubitemid 44485986)
74. Mantovani, A. (2005). Cancer: inflammation by remote control. Nature 435, 752 753. (Pubitemid 40839716)
75. Mantovani, A., Allavena, P., Sica, A. Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436 444.
76. Marathe, G.K., Johnson, C., Billings, S.D., Southall, M.D., Pei, Y., Spandau, D., Murphy, R.C., Zimmerman, G.A., McIntyre, T.M. Travers, J.B. (2005). Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J. Biol. Chem. 280, 35448 35457. (Pubitemid 41532735)
77. Massi, D., Naldini, A., Ardinghi, C. et al. (2005). Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum. Pathol. 36, 676 685. (Pubitemid 40922575)
78. Mattei, S., Colombo, M.P., Melani, C., Silvani, A., Parmiani, G. Herlyn, M. (1994). Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer 56, 853 857. (Pubitemid 24102753)
79. Melnikova, V.O. Bar-Eli, M. (2006). Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 19, 395 405. (Pubitemid 44326401)
80. Melnikova, V.O. Bar-Eli, M. (2008). Transcriptional control of the melanoma malignant phenotype. Cancer Biol. Ther. 7, 997 1003.
81. Melnikova, V.O., Mourad-Zeidan, A.A., Lev, D.C. Bar-Eli, M. (2006). Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J. Biol. Chem. 281, 2911 2922. (Pubitemid 43845757)
82. Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., van der Horst, C.M., Majoor, D.M., Shay, J.W., Mooi, W.J. Peeper, D.S. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720 724. (Pubitemid 41117276)
83. Miller, A.J. Mihm, M.C. Jr. (2006). Melanoma. N. Engl. J. Med. 355, 51 65.
84. Mohle, R., Green, D., Moore, M.A., Nachman, R.L. Rafii, S. (1997). Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U S A 94, 663 668. (Pubitemid 27053690)
85. Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G. Camussi, G. (1994). Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180, 377 382. (Pubitemid 24181088)
86. Montrucchio, G., Lupia, E., de Martino, A., Battaglia, E., Arese, M., Tizzani, A., Bussolino, F. Camussi, G. (1997). Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am. J. Pathol. 151, 557 563. (Pubitemid 27330075)
87. Montrucchio, G., Sapino, A., Bussolati, B., Ghisolfi, G., Rizea-Savu, S., Silvestro, L., Lupia, E. Camussi, G. (1998). Potential angiogenic role of platelet-activating factor in human breast cancer. Am. J. Pathol. 153, 1589 1596. (Pubitemid 28509916)
88. Moretti, S., Pinzi, C., Spallanzani, A., Berti, E., Chiarugi, A., Mazzoli, S., Fabiani, M., Vallecchi, C. Herlyn, M. (1999). Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int. J. Cancer 84, 160 168. (Pubitemid 29133828)
89. Mrowietz, U., Schwenk, U., Maune, S., Bartels, J., Kupper, M., Fichtner, I., Schroder, J.M. Schadendorf, D. (1999). The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br. J. Cancer 79, 1025 1031. (Pubitemid 29087870)
90. Murakami, T., Maki, W., Cardones, A.R., Fang, H., Tun Kyi, A., Nestle, F.O. Hwang, S.T. (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62, 7328 7334. (Pubitemid 36025256)
91. Nakamura, M., Honda, Z., Izumi, T. et al. (1991). Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J. Biol. Chem. 266, 20400 20405. (Pubitemid 21908472)
92. Navarini-Meury, A.A. Conrad, C. (2008). Melanoma and innate immunity - Active inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines Semin. Cancer Biol. 19, 84 91.
93. Nierodzik, M.L. Karpatkin, S. (2006). Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10, 355 362.
94. Nierodzik, M.L., Bain, R.M., Liu, L.X., Shivji, M., Takeshita, K. Karpatkin, S. (1996). Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br. J. Haematol. 92, 452 457. (Pubitemid 26042943)
95. Nierodzik, M.L., Chen, K., Takeshita, K., Li, J.J., Huang, Y.Q., Feng, X.S., D'Andrea, M.R., Andrade-Gordon, P. Karpatkin, S. (1998). Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92, 3694 3700. (Pubitemid 28525196)
96. Noonan, F.P., Recio, J.A., Takayama, H., Duray, P., Anver, M.R., Rush, W.L., De Fabo, E.C. Merlino, G. (2001). Neonatal sunburn and melanoma in mice. Nature 413, 271 272. (Pubitemid 32905840)
97. Norgauer, J., Metzner, B. Schraufstatter, I. (1996). Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol. 156, 1132 1137. (Pubitemid 26048108)
98. O'Brien, P.J., Molino, M., Kahn, M. Brass, L.F. (2001). Protease activated receptors: theme and variations. Oncogene 20, 1570 1581. (Pubitemid 32336845)
99. Owen, J.D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R. Richmond, A. (1997). Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int. J. Cancer 73, 94 103. (Pubitemid 27445996)
100. Padua, D. Massague, J. (2009). Roles of TGFbeta in metastasis. Cell Res. 19, 89 102.
101. Pei, Y., Barber, L.A., Murphy, R.C., Johnson, C.A., Kelley, S.W., Dy, L.C., Fertel, R.H., Nguyen, T.M., Williams, D.A. Travers, J.B. (1998). Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J. Immunol. 161, 1954 1961. (Pubitemid 28387619)
102. Postovit, L.M., Margaryan, N.V., Seftor, E.A. Hendrix, M.J. (2008). Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res. 21, 348 357.
103. Remmel, E., Terracciano, L., Noppen, C., Zajac, P., Heberer, M., Spagnoli, G.C. Padovan, E. (2001). Modulation of dendritic cell phenotype and mobility by tumor cells in vitro. Hum. Immunol. 62, 39 49. (Pubitemid 32163933)
104. Ribatti, D., Ennas, M.G., Vacca, A., Ferreli, F., Nico, B., Orru, S. Sirigu, P. (2003a). Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Invest. 33, 420 425. (Pubitemid 36583711)
105. Ribatti, D., Vacca, A., Ria, R., Marzullo, A., Nico, B., Filotico, R., Roncali, L. Dammacco, F. (2003b). Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer 39, 666 674. (Pubitemid 36287380)
106. Richmond, A., Yang, J. Su, Y. (2009). The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res. 22, 175 186.
107. Robert, E.G. Hunt, J.D. (2001). Lipid messengers as targets for antiangiogenic therapy. Curr. Pharm. Des. 7, 1615 1626. (Pubitemid 32998574)
108. Robinson, S.C. Coussens, L.M. (2005). Soluble mediators of inflammation during tumor development. Adv. Cancer Res. 93, 159 187. (Pubitemid 41557275)
109. Rollin, S., Lemieux, C., Maliba, R., Favier, J., Villeneuve, L.R., Allen, B.G., Soker, S., Bazan, N.G., Merhi, Y. Sirois, M.G. (2004). VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis. Blood 103, 3789 3797. (Pubitemid 38596297)
110. Roth, M., Nauck, M., Yousefi, S., Tamm, M., Blaser, K., Perruchoud, A.P. Simon, H.U. (1996). Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J. Exp. Med. 184, 191 201. (Pubitemid 26247229)
111. Rubtsov, Y.P. Rudensky, A.Y. (2007). TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7, 443 453. (Pubitemid 46834850)
112. Rudroff, C., Schafberg, H., Nowak, G., Weinel, R., Scheele, J. Kaufmann, R. 1998). Characterization of functional thrombin receptors in human pancreatic tumor cells (MIA PACA-2). Pancreas 16, 189 194. (Pubitemid 28117204)
113. Ruf, W. (2007). Tissue factor and PAR signaling in tumor progression. Thromb. Res. 120 (Suppl 2 S7 S12. (Pubitemid 350101768)
114. Ruf, W. Mueller, B.M. (2006). Thrombin generation and the pathogenesis of cancer. Semin. Thromb. Hemost. 32 (Suppl 1 61 68.
115. Rutberg, S.E., Goldstein, I.M., Yang, Y.M., Stackpole, C.W. Ronai, Z. (1994). Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma subclones. Mol. Carcinog. 10, 82 87. (Pubitemid 24246961)
116. Sato, S., Kume, K., Ito, C., Ishii, S. Shimizu, T. (1999). Accelerated proliferation of epidermal keratinocytes by the transgenic expression of the platelet-activating factor receptor. Arch. Dermatol. Res. 291, 614 621.
117. Schall, T.J., Bacon, K., Toy, K.J. Goeddel, D.V. (1990). Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347, 669 671. (Pubitemid 20356243)
118. Schwarz, T. Luger, T.A. (1989). Effect of UV irradiation on epidermal cell cytokine production. J. Photochem. Photobiol. B 4, 1 13.
119. Senger, D.R., Ledbetter, S.R., Claffey, K.P., Papadopoulos-Sergiou, A., Peruzzi, C.A. Detmar, M. (1996). Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149, 293 305. (Pubitemid 26231000)
120. Seo, K.H., Ko, H.M., Choi, J.H., Jung, H.H., Chun, Y.H., Choi, I.W., Lee, H.K. Im, S.Y. (2004). Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. Eur. J. Immunol. 34, 2129 2137. (Pubitemid 39256094)
121. Shimizu, S., Gabazza, E.C., Hayashi, T., Ido, M., Adachi, Y. Suzuki, K. (2000). Thrombin stimulates the expression of PDGF in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L503 L510.
122. Sirois, M.G. Edelman, E.R. (1997). VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am. J. Physiol. 272, H2746 H2756. (Pubitemid 27300451)
123. Tellez, C. Bar-Eli, M. (2003). Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22, 3130 3137. (Pubitemid 36713765)
124. Tellez, C., McCarty, M., Ruiz, M. Bar-Eli, M. (2003). Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J. Biol. Chem. 278, 46632 46642. (Pubitemid 37452239)
125. Tellez, C.S., Davis, D.W., Prieto, V.G., Gershenwald, J.E., Johnson, M.M., McCarty, M.F. Bar-Eli, M. (2007). Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. J. Invest. Dermatol. 127, 387 393. (Pubitemid 46106918)
126. Timar, J., Tovari, J., Raso, E., Meszaros, L., Bereczky, B. Lapis, K. (2005). Platelet-mimicry of cancer cells: epiphenomenon with clinical significance. Oncology 69, 185 201. (Pubitemid 41433577)
127. Tlsty, T.D. Coussens, L.M. (2006). Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 1, 119 150.
128. Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S. Kuwano, M. (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int. J. Cancer 85, 182 188. (Pubitemid 30023065)
129. Ueno, A., Murakami, K., Yamanouchi, K., Watanabe, M. Kondo, T. (1996). Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells. Immunology 88, 76 81. (Pubitemid 26166379)
130. Ullrich, S.E. (2005). Mechanisms underlying UV-induced immune suppression. Mutat. Res. 571, 185 205. (Pubitemid 40313441)
131. Villanueva, J. Herlyn, M. (2008). Melanoma and the tumor microenvironment. Curr. Oncol. Rep. 10, 439 446.
132. Villares, G.J., Zigler, M., Wang, H. et al. (2008). Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res. 68, 9078 9086.
133. Walterscheid, J.P., Ullrich, S.E. Nghiem, D.X. (2002). Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195, 171 179. (Pubitemid 34461261)
134. Weber, J.S. (2008). Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma. J. Invest. Dermatol. 128, 2750 2752.
135. Witz, I.P. (2008). Tumor-microenvironment interactions: dangerous liaisons. Adv. Cancer Res. 100, 203 229.
136. Wojtukiewicz, M.Z., Tang, D.G., Nelson, K.K., Walz, D.A., Diglio, C.A. Honn, K.V. (1992). Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface. Thromb. Res. 68, 233 245.
137. Wojtukiewicz, M.Z., Tang, D.G., Ben-Josef, E., Renaud, C., Walz, D.A. Honn, K.V. (1995). Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res. 55, 698 704.
138. Yang, J., Luan, J., Yu, Y., Li, C., DePinho, R.A., Chin, L. Richmond, A. (2001). Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res. 61, 8150 8157. (Pubitemid 33091606)
139. Ye, R.D., Prossnitz, E.R., Zou, A.H. Cochrane, C.G. (1991). Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem. Biophys. Res. Commun. 180, 105 111.
140. Zhang, C., Zhang, F., Tsan, R. Fidler, I.J. (2009). Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res. 69, 828 835.
141. Zucker, S., Conner, C., DiMassmo, B.I., Ende, H., Drews, M., Seiki, M. Bahou, W.F. (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J. Biol. Chem. 270, 23730 23738.